last Monday (2/8), ANVISA approved the start of the clinical study to evaluate the safety and efficacy of the drug leronlimab and n the treatment of patients moderately ill with pneumonia caused by Covid-19.
It's definitely just a health and safety evaluation at this point. Get over it.